|
CDK14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.323600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.330300E-02 |
| Normal-vs-Stage2 |
4.790600E-01 |
| Normal-vs-Stage3 |
3.505800E-02 |
| Normal-vs-Stage4 |
2.120400E-01 |
| Stage1-vs-Stage2 |
6.779400E-01 |
| Stage1-vs-Stage3 |
5.688800E-01 |
| Stage1-vs-Stage4 |
9.706800E-01 |
| Stage2-vs-Stage3 |
4.522400E-01 |
| Stage2-vs-Stage4 |
7.806600E-01 |
| Stage3-vs-Stage4 |
7.267800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.638100E-02 |
| Normal-vs-AfricanAmerican |
3.122600E-01 |
| Normal-vs-Asian |
2.666800E-01 |
| Caucasian-vs-AfricanAmerican |
5.351000E-01 |
| Caucasian-vs-Asian |
8.158200E-01 |
| AfricanAmerican-vs-Asian |
6.930000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.680100E-02 |
| Normal-vs-Female |
4.454200E-01 |
| Male-vs-Female |
2.846600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.444700E-03 |
| Normal-vs-Extreme_Weight |
4.833800E-02 |
| Normal-vs-Obese |
5.706400E-01 |
| Normal-vs-Extreme_Obese |
2.174800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.366200E-01 |
| Normal_Weight-vs-Obese |
2.142100E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.148000E-01 |
| Extreme_Weight-vs-Obese |
1.846170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.404000E-01 |
| Obese-vs-Extreme_Obese |
5.335800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.664780E-01 |
| Normal-vs-Age(41-60Yrs) |
3.421000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.014500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.606440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.361000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.311400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.729400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.448400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.438400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.969800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.001800E-01 |
| Normal-VS-Type2 PRCC |
6.397000E-03 |
| Normal-VS-KIRP CIMP |
1.150010E-01 |
| Normal-VS-Unclassified PRCC |
8.012800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.641800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.175800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.032200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.729000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.755600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.378980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.988000E-02 |
| Normal-vs-N1 |
6.944300E-02 |
| Normal-vs-N2 |
4.774600E-01 |
| N0-vs-N1 |
8.831600E-01 |
| N0-vs-N2 |
8.003200E-01 |
| N1-vs-N2 |
8.087400E-01 |
|
|
